128 related articles for article (PubMed ID: 12006553)
1. Correspondence re: M. Follen et al., a randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
Formelli F
Clin Cancer Res; 2002 May; 8(5):1310-2; author reply 1313. PubMed ID: 12006553
[No Abstract] [Full Text] [Related]
2. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
Follen M; Atkinson EN; Schottenfeld D; Malpica A; West L; Lippman S; Zou C; Hittelman WN; Lotan R; Hong WK
Clin Cancer Res; 2001 Nov; 7(11):3356-65. PubMed ID: 11705848
[TBL] [Abstract][Full Text] [Related]
3. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Fonseca BO; Possati-Resende JC; Salcedo MP; Schmeler KM; Accorsi GS; Fregnani JHTG; Antoniazzi M; Pantano NP; Santana IVV; Matsushita GM; Dos Reis R
Obstet Gynecol; 2021 Jun; 137(6):1043-1053. PubMed ID: 33957649
[TBL] [Abstract][Full Text] [Related]
4. Correspondence re: A. Manetta et al., Beta-carotene treatment of cervical intraepithelial neoplasia: a phase II study. Cancer Epidemiol., Biomarkers & Prev., 5: 929-932, 1996.
Torné A; Puig-Tintoré LM; Ordi J; Sánchez E
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):655-6. PubMed ID: 9264282
[No Abstract] [Full Text] [Related]
5. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
6. Quantitative histopathology and chromosome 9 polysomy in a clinical trial of 4-HPR.
Yamal JM; Cox D; Hittelman WN; Boiko I; Malpica A; Guillaud M; MacAulay C; Follen M; Vlastos AT
Gynecol Oncol; 2004 Aug; 94(2):296-306. PubMed ID: 15297165
[TBL] [Abstract][Full Text] [Related]
7. Retinoids for preventing the progression of cervical intra-epithelial neoplasia.
Helm CW; Lorenz DJ; Meyer NJ; Rising WR; Wulff JL
Cochrane Database Syst Rev; 2007 Oct; (4):CD003296. PubMed ID: 17943787
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic HPV vaccine for cervical intraepithelial neoplasia.
Burki TK
Lancet Oncol; 2019 May; 20(5):e250. PubMed ID: 30987938
[No Abstract] [Full Text] [Related]
9. 5-FU for maintenance therapy of cervical lesions.
Hanna L
BETA; 1999 Apr; 12(2):17. PubMed ID: 11366681
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions: a substudy of a randomized, phase III chemoprevention trial.
Robinson WR; Luck MB; Kendall MA; Darragh TM
Am J Obstet Gynecol; 2003 Apr; 188(4):896-900. PubMed ID: 12712082
[TBL] [Abstract][Full Text] [Related]
11. Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trial.
Kim HG; Yamal JM; Xu XC; Hu W; Boiko I; Linares A; Vlastos AT; Atkinson EN; Malpica A; Hittelman WN; Follen M
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S32-7. PubMed ID: 16154183
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
Meyskens FL; Surwit E; Moon TE; Childers JM; Davis JR; Dorr RT; Johnson CS; Alberts DS
J Natl Cancer Inst; 1994 Apr; 86(7):539-43. PubMed ID: 8133537
[TBL] [Abstract][Full Text] [Related]
13. Cervical dysplasia regression induced by all-trans-retinoic acid.
Sporn MB; Roberts AB
J Natl Cancer Inst; 1994 Apr; 86(7):476-7. PubMed ID: 8133526
[No Abstract] [Full Text] [Related]
14. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
[TBL] [Abstract][Full Text] [Related]
15. Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.
Koeneman MM; Kruse AJ; Kooreman LF; Zur Hausen A; Hopman AH; Sep SJ; Van Gorp T; Slangen BF; van Beekhuizen HJ; van de Sande AJ; Gerestein CG; Nijman HW; Kruitwagen RF
BMC Cancer; 2017 Feb; 17(1):110. PubMed ID: 28173776
[TBL] [Abstract][Full Text] [Related]
16. Topical Therapy With Imiquimod for Vaginal Intraepithelial Neoplasia: A Case Series.
Policiano AC; Lopes JP; Barata SA; Colaço AM; Calhaz-Jorge C
J Low Genit Tract Dis; 2016 Jul; 20(3):e34-6. PubMed ID: 27158879
[No Abstract] [Full Text] [Related]
17. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
Pachman DR; Barton DL; Clayton AC; McGovern RM; Jefferies JA; Novotny PJ; Sloan JA; Loprinzi CL; Gostout BS
Am J Obstet Gynecol; 2012 Jan; 206(1):42.e1-7. PubMed ID: 21907959
[TBL] [Abstract][Full Text] [Related]
18. Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.
Vlastos AT; West LA; Atkinson EN; Boiko I; Malpica A; Hong WK; Follen M
Clin Cancer Res; 2005 Jan; 11(1):390-6. PubMed ID: 15671570
[TBL] [Abstract][Full Text] [Related]
19. Using cytokines to treat cervical intraepithelial and invasive neoplasia.
Tirone NR; Michelin MA; Murta EF
Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):165-9. PubMed ID: 19961435
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
de Witte CJ; van de Sande AJ; van Beekhuizen HJ; Koeneman MM; Kruse AJ; Gerestein CG
Gynecol Oncol; 2015 Nov; 139(2):377-84. PubMed ID: 26335596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
